Innovative medicine patent policy in India
Prepared a white paper for the National Association of Manufacturers (NAM) to evaluate restrictive trade policies in place in India, among which is failure to grant patents on innovative medicines. The report accompanies NAM’s submission to the United States International Trade Commission which is conducting an investigation into trade and industrial policies in India as they affect the US economy.